Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center
home
Articles
Future of NTRK Fusions
May 21st 2020
Challenges for TRK Fusion–Targeting Agents
May 21st 2020
Acquired Resistance in TRK Fusion-Positive Cancers
May 21st 2020
Approaching Treatment for TRK Fusion–Positive Cancers
May 21st 2020
TRK Inhibitor in GI Cancers: Adverse Effect Profile
May 21st 2020
Efficacy of TRK Inhibitors
May 21st 2020
Early Development of TRK Inhibitors
May 21st 2020
Advice for Interpreting NGS Reports
May 21st 2020
Driver Mutations in NTRK Fusion-Positive Cancers
May 21st 2020
Genomic Testing for NTRK Fusions in Lung and GI Cancers
May 21st 2020
Approaching Genomic Testing for NTRK Fusions
May 21st 2020
Using Molecular Testing in GI Cancers
May 21st 2020
Evolution of NGS Testing in Lung Cancers
May 21st 2020
Variants of NTRK Fusions in Solid Tumors
May 21st 2020
Role of NTRK Inhibitors
May 21st 2020